Free shipping on all orders over $ 500


Cat. No. M1737
MF63 Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
2mg USD 50  USD50 In stock
5mg USD 100  USD100 In stock
10mg USD 160  USD160 In stock
50mg USD 640  USD640 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

MF63 potently inhibited the human mPGES-1 enzyme (IC50=1.3 nM), with a high degree (>1000-fold) of selectivity over other prostanoid synthases. Microsomal prostaglandin E synthase-1 (mPGES-1) is a terminal prostaglandin E (2) (PGE (2)) synthase in the cyclooxygenase pathway. Inhibitors of mPGES-1 may block PGE (2) production and relieve inflammatory symptoms. In rodent species, MF63 strongly inhibited guinea pig mPGES-1 (IC50=0.9 nM) but not the mouse or rat enzyme. In addition, MF63 did not cause NSAID-like gastrointestinal toxic effects, such as mucosal erosions or leakage in the KI mice or nonhuman primates, although it markedly inhibited PGE2 synthesis in the KI mouse stomach.

Product Citations
Customer Product Validations & Biological Datas
Source Oncotarget (2016). Figure 4. MF63 (Abmole Bioscience, Houston, TX, USA)
Cell Lines mPGES-1+/+ cells
Concentrations 10 μM
Incubation Time 18 h
Results Moreover, MF63 increased levels of both miRs in mPGES-1+/+ cells (Figure 4C), and miR-15a and miR-186 were up-regulated with respect to mPGES-1+/+ tumors in DU145 mPGES-1-/- xenografts in vivo (Figure 4D).
Source Oncotarget (2016). Figure 3. MF63 (Abmole Bioscience, Houston, TX, USA)
Cell Lines mPGES-1+/+ cells
Concentrations 10 μM
Incubation Time
Results Consistently,MF63 (10 μM) significantly increased Dicer expression in mPGES-1+/+ cells (Figure 3B), whereas exogenous PGE-2(1 μM, 2–24 h) decreased in mPGES-1-/- cells (Figure 3C).
Source Oncotarget (2016). Figure 1. MF63 (Abmole Bioscience, Houston, TX, USA)
Cell Lines mPGES-1+/+ cells
Concentrations 10 μM
Incubation Time
Results MF63 (10 μM), a reversible mPGES-1 inhibitor, significantly decreased VEGF expression in mPGES-1+/+ cells with maximum effect at 8–18 h (Figure 1D), while exogenous PGE-2 (1 μM) increased VEGF release and expression in mPGES-1-/- cells time-dependently (Figure 1B, 1E).
Source Am J Physiol Gastrointest Liver Physiol (2016) . Figure 4.mPGES-1 inhibitor MF63 (Abmole bioscience, Houston, TX)
Method Western blotting analysis
Cell Lines
Concentrations 1µM
Incubation Time 6 h
Results The above effects were attenuated by pretreatment with the mPGES-1 inhibitor, MF63, in Jo2-treated mPGES-1 Tg mice (Fig. 4A). These findings indicate an important role of EGFR/Akt and associated apoptosis-regulatory molecules in mPGES-1-mediated protection against liver injury.
Source Am J Physiol Gastrointest Liver Physiol (2016) . Figure 1.mPGES-1 inhibitor MF63 (Abmole bioscience, Houston, TX)
Method mPGES-1 Tg mice oral gavage (twice every 12 h)
Cell Lines
Concentrations 50µg/g body weight
Incubation Time 5 h
Results Two doses of MF63 were administrated via oral gavage (every 12h) before Jo2 injection and the mice were sacrificed 5 hours after Jo2 injection (outlined in Fig. 3A). We observed that MF63 pretreatment partially reversed the resistance of mPGES-1 Tg mice to Jo2-induced liver injury (Fig. 3B-F).These findings further support the role of mPGES-1 in modulation of Fas-induced hepatocyte apoptosis and liver injury.
Source Endocrinology (2015) . Figure 4. MF63 was from AbMole.
Method EIA assay and western blot analysis
Cell Lines DU145, PC-3
Concentrations 10 µ M
Incubation Time 48 h
Results MF63 (10 µmol l-1, 24-48 h) significantly inhibited PGE2 production and reversed the mesenchymal phenotype in DU145 and PC-3 cells, promoting E-cadherin and inhibiting vimentin expression (Fig. 4A, B and C). MF63 also upregulated α6-integrin and significantly reduced cell clonogenicity (Fig.4D, and E).
Protocol (for reference only)
Cell Experiment
Cell lines A549 cells
Preparation method A549 cells were seeded in 96-well dishes at a density of 25,000 cells/well and incubated for 20 h in RPMI 1640 medium supplemented with 2% fetal bovine serum (FBS). The cells were then incubated with 10 ng/ml IL-1 for 24 h in the presence of a vehicle or inhibitor from a 100-fold concentrated DMSO stock solution in a medium containing 2 or 50% FBS. Concentrations of PGE2 and PGF2 in the cell-free medium were measured by EIA (Assay Designs Inc.). IC50 values were derived from eight-point titrations.
Concentrations 0.01~100 µ M
Incubation time 24 h
Animal Experiment
Animal models mPGES-1 Knock-In Mice
Formulation a suspension in 0.5% methylcellulose
Dosages 100 mg/kg
Administration oral gavage
Chemical Information
Molecular Weight 378.81
Formula C23H11ClN4
CAS Number 892549-43-8
Solubility (25°C) DMSO 42 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.


[1] Xu et al. J Pharmacol Exp Ther. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.

Related PGE synthase Products

Friluglanstat is a prostaglandin E synthase (mPGES-1) inhibitor, with anti-inflammatory activity.


UT-11 is a potent and brain-permeable microsomal prostaglandin E synthase-1 (mPGES-1) inhibitor.


CAY10526 is a specific microsomal PGE2 synthase-1 (mPGES1) inhibitor. CAY10526 inhibits PGE2 production through the selective modulation of mPGES1 expression but does not affect COX-2. CAY10526 significantly suppresses tumor growth and increases apoptosis in melanoma xenografts. CAY10526 reduces BCL-2 and BCL-XL (anti-apoptotic) protein levels and increases BAX and BAK (pro-apoptotic) as well as cleaved caspase 3 levels. CAY10526 inhibits cell viability (IC50<5 μM) in three melanoma cell lines expressing mPGES1.

HPGDS inhibitor 2 

HPGDS inhibitor 2 is a highly potent and selective hematopoietic prostaglandin D synthase (H-PGDS) inhibitor with an IC50 of 9.9 nM.


PF-4693627 is a potent, selective and orally bioavailable microsomal prostaglandin E synthase-1 (mPGES-1) inhibitor (IC50=3 nM) for the treatment of inflammation caused by osteoarthritis (OA) and rheumatoid arthritis (RA).

Abmole Inhibitor Catalog

Keywords: MF63 supplier, PGE synthase, inhibitors, activators

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.